Optic nerve sheath meningioma detected by somatostatin receptor scintigraphy with [99mTc]Tc-Tektrotyd
, 2, 1, 1, 1
Abstract
Optic nerve sheath meningiomas are rare and difficult to diagnose accurately due to the high risk of visual loss associated with histologic confirmation. Currently, the primary imaging techniques used for diagnosis are contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI). However, these methods may not always provide a definitive diagnosis, necessitating alternative approaches. This case study is one of the few that reports the use of a [99mTc]Tc-Tektrotyd single-photon emission computed tomography (SPECT/CT) scan for the non-invasive diagnosis of an orbital space-occupying tumor. This radiopharmaceutical can bind with high affinity to somatostatin receptor subtype 2, which is expressed in meningiomas.
Keywords: optic nerve sheath meningiomasoctreoscan[99mTc]Tc-TektrotydSSTR2
References
- Smee RI, Schneider M, Williams JR. Optic nerve sheath meningiomas — non-surgical treatment. Clin Oncol (R Coll Radiol). 2009; 21(1): 8–13.
- Nathoo N, Ugokwe K, Chang AS, et al. The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas. J Neurooncol. 2007; 81(2): 167–174.
- Dutour A, Kumar U, Panetta R, et al. Expression of somatostatin receptor subtypes in human brain tumors. Int J Cancer. 1998; 76(5): 620–627, doi: 10.1002/(sici)1097-0215(19980529)76:5<620::aid-ijc2>3.0.co;2-s.
- Kiviniemi A, Gardberg M, Kivinen K, et al. Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome. Oncotarget. 2017; 8(30): 49123–49132.
- Nussbaum-Hermassi L, Ahle G, Zaenker C, et al. Optic nerve sheath meningioma detected by single- photon emission computed tomography/computed tomography somatostatin receptor scintigraphy: a case report. J Med Case Rep. 2016; 10(1): 96.
- Garai I, Barna S, Nagy G, et al. Limitations and pitfalls of 99mTc-EDDA/HYNIC-TOC (Tektrotyd) scintigraphy. Nucl Med Rev Cent East Eur. 2016; 19(2): 93–98.
